Emerging evidence suggests that cancer cells utilize various mechanisms to gain a competitive advantage over immune cells in acquiring and utilizing glutamine [7, 23]
Priced separately and entirely optional
Sharma, United States Department of Health and Human Services, United States Cecilia Sderberg-Nauclr, Karolinska Institutet (KI), Sweden Updates Copyright 2024 Saito, Shahbaz, Luo, Osman, Redmond, Cohen Tervaert, Li and Elahi
However, as is the case with xenosiderophores, iron-containing chelating molecules such as desferrioxamine B (DFO), used in the treatment of iron-loading disorders, can be utilised as an iron source by bacteria that harbour the necessary receptor, including NTHi (Williams et al., 1990